|
 |
Genome > Peptide
.jpg)
The following information is about Peptide.
Peptide Defined
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at ...
Published August 19, 2008, 11:30 am, Centre Daily Times
Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theory regarding a potential mechanism of action, which could advance HIV/AIDS research and the development of an inexpensive, effective therapy for HIV. The study team says some of the study findings may also be applicable to autoimmune disease. Viral Genetics ...
Viral Genetics, Inc. Unveils Potential Mechanism of Action in HIV/AIDS Research, Accepted to Present Findings at ...
Published August 19, 2008, 11:02 am, Business Wire via Yahoo! Finance
AZUSA, Calif.----Viral Genetics, Inc. , a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theory regarding a potential mechanism of action, which could advance HIV/AIDS research and the development of an inexpensive, effective therapy for HIV.
New Ribosomal Research Offers Fresh Evidence, Understanding of Evolution
Published August 19, 2008, 5:45 am, AnandTech
Skepticism aside, evolution is steadily being verified and analyzed thanks to cutting edge computing...
Studies Describing Novel Approaches To Maximizing Dicer-Substrate Small Interfering RNAs Published
Published August 14, 2008, 2:17 am, Medical News Today
Dicerna Pharmaceuticals, Inc., a second generation RNA interference company developing novel therapeutics utilizing proprietary Dicer Substrate Technology™, today announced key studies highlighting the therapeutic potential for Dicer-substrate small interfering RNAs (DsiRNAs). The first study, co-authored by Dicerna co-founder John Rossi, Ph.D.
Jean-Marie Eveillard Buys Wells Fargo & Company, Discovery Holding Company Series A, WH Energy Services Inc., Sells ...
Published August 13, 2008, 5:26 pm, Guru Focus
At the end of April, Jean-Marie Eveillard did not see much opportunites. But it seems that he saw a lof of them during the second quarter. He made new buys in varieties of companies. These are his buys and sells during the second quarter. Jean-Marie Eveillard owns 337 stocks with a total value of $11.2 billion.
Are you looking for additional Genome > Peptide news? Try our new "Peptide News Focus" area.
Off-site Peptide Links, User Submitted
The following links have been collected through user bookmark submission in the Peptide category. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Wed Aug 13
Fri Aug 1
Mon Jul 28
Sun Jul 27
- peptide: peptide
Fri Jul 25
Mon Jul 14
Wed Jul 2
Tue Jun 24
- Peptide Bond Formation Animation: Peptide Bond Formation Animation
Sat Jun 14
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Peptide. If you would like to find related tags we recommend Tag Patterns > Peptide
Off-site Peptide Research Links
If you still need additional information on Peptide then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
Genome Topics
Everything you need to know about Genome
Genome
If you know the Genome Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Genome.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.